[HTML][HTML] VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread

X Li, N Padhan, EO Sjöström, FP Roche… - Nature …, 2016 - nature.com
X Li, N Padhan, EO Sjöström, FP Roche, C Testini, N Honkura, M Sáinz-Jaspeado
Nature communications, 2016nature.com
The specific role of VEGFA-induced permeability and vascular leakage in physiology and
pathology has remained unclear. Here we show that VEGFA-induced vascular leakage
depends on signalling initiated via the VEGFR2 phosphosite Y949, regulating dynamic c-Src
and VE-cadherin phosphorylation. Abolished Y949 signalling in the mouse mutant Vegfr2
Y949F/Y949F leads to VEGFA-resistant endothelial adherens junctions and a block in
molecular extravasation. Vessels in Vegfr2 Y949F/Y949F mice remain sensitive to …
Abstract
The specific role of VEGFA-induced permeability and vascular leakage in physiology and pathology has remained unclear. Here we show that VEGFA-induced vascular leakage depends on signalling initiated via the VEGFR2 phosphosite Y949, regulating dynamic c-Src and VE-cadherin phosphorylation. Abolished Y949 signalling in the mouse mutant Vegfr2Y949F/Y949F leads to VEGFA-resistant endothelial adherens junctions and a block in molecular extravasation. Vessels in Vegfr2Y949F/Y949F mice remain sensitive to inflammatory cytokines, and vascular morphology, blood pressure and flow parameters are normal. Tumour-bearing Vegfr2Y949F/Y949F mice display reduced vascular leakage and oedema, improved response to chemotherapy and, importantly, reduced metastatic spread. The inflammatory infiltration in the tumour micro-environment is unaffected. Blocking VEGFA-induced disassembly of endothelial junctions, thereby suppressing tumour oedema and metastatic spread, may be preferable to full vascular suppression in the treatment of certain cancer forms.
nature.com